<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39376643</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2213-0071</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Respiratory medicine case reports</Title><ISOAbbreviation>Respir Med Case Rep</ISOAbbreviation></Journal><ArticleTitle>Intravascular large B-cell lymphoma with respiratory failure diagnosed by random skin biopsy: A case report.</ArticleTitle><Pagination><StartPage>102115</StartPage><MedlinePgn>102115</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102115</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmcr.2024.102115</ELocationID><Abstract><AbstractText>Intravascular large B-cell lymphoma (IVLBCL) typically involves nonspecific symptoms that complicate diagnosis. This report discusses the case of a 70-year-old man, who presented with dyspnea, fatigue, and weight loss that evolved into severe respiratory failure, diagnosed with IVLBCL via random skin biopsy. The initial improvement in respiratory symptoms was followed by coronavirus disease. Response to steroid therapy and elevated lactate dehydrogenase levels suggested IVLBCL, confirmed by a random skin biopsy. The combination chemotherapy of rituximab, cyclophosphamide, vincristine, doxorubicin, and prednisolone improved the respiratory condition. This case highlights the diagnostic challenges associated with IVLBCL and the crucial role of random skin biopsy.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujioka</LastName><ForeName>Haruka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakashima</LastName><ForeName>Kei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uesugi</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyui</LastName><ForeName>Miki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoshima</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimi</LastName><ForeName>Michinori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsumata</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diabetes and Endocrinology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diabetes and Endocrinology, Nara Medical University, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuzawa</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Diabetes and Endocrinology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usami</LastName><ForeName>Hayato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Akane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabata</LastName><ForeName>Rikako</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsue</LastName><ForeName>Kosei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, Kameda Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Med Case Rep</MedlineTA><NlmUniqueID>101604463</NlmUniqueID><ISSNLinking>2213-0071</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intravascular large B-Cell lymphoma</Keyword><Keyword MajorTopicYN="N">Random skin biopsy</Keyword><Keyword MajorTopicYN="N">Respiratory failure</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39376643</ArticleId><ArticleId IdType="pmc">PMC11456914</ArticleId><ArticleId IdType="doi">10.1016/j.rmcr.2024.102115</ArticleId><ArticleId IdType="pii">S2213-0071(24)00138-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ponzoni M., Campo E., Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood. 2018;132(15):1561–1567.</Citation><ArticleIdList><ArticleId IdType="pubmed">30111607</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio P., Hall P.A., Cotter F., et al. Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol. Oncol. 1989;7(3):195–206.</Citation><ArticleIdList><ArticleId IdType="pubmed">2651272</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Li Q., Wang D., et al. Case report: intravascular large B-cell lymphoma: a clinicopathologic study of four cases with review of additional 331 cases in the literature. Front. Oncol. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9135977</ArticleId><ArticleId IdType="pubmed">35646671</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Miyagaki T., Okano T., Takeuchi S., Kadono T. Predictive factors and scoring system for intravascular large B-cell lymphoma among suspected cases: a single-center retrospective analysis. Int. J. Dermatol. 2024;63(1):79–84.</Citation><ArticleIdList><ArticleId IdType="pubmed">37955167</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder L.S., Harmon K.R., Estensen R.D. Intravascular lymphomatosis (malignant angioendotheliomatosis) presenting as pulmonary hypertension. Chest. 1989;96(5):1199–1200.</Citation><ArticleIdList><ArticleId IdType="pubmed">2805852</ArticleId></ArticleIdList></Reference><Reference><Citation>Aouba A., Diop S., Saadoun D., et al. Severe pulmonary arterial hypertension as initial manifestation of intravascular lymphoma: case report. Am. J. Hematol. 2005;79(1):46–49.</Citation><ArticleIdList><ArticleId IdType="pubmed">15849762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreri A.J., Campo E., Seymour J.F., et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant. Br. J. Haematol. 2004;127(2):173–183.</Citation><ArticleIdList><ArticleId IdType="pubmed">15461623</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirer T., Dail D.H., Aboulafia D.M. Four varied cases of intravascular lymphomatosis and a literature review. Cancer. 1994;73(6):1738–1745.</Citation><ArticleIdList><ArticleId IdType="pubmed">8156502</ArticleId></ArticleIdList></Reference><Reference><Citation>Takamura K., Nasuhara Y., Mishina T., et al. Intravascular lymphomatosis diagnosed by transbronchial lung biopsy. Eur. Respir. J. 1997;10(4):955–957.</Citation><ArticleIdList><ArticleId IdType="pubmed">9150341</ArticleId></ArticleIdList></Reference><Reference><Citation>Khojeini E.V., Song J.Y. Intravascular large B-cell lymphoma presenting as interstitial lung disease. Case Rep Pathol. 2014;928065:2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052500</ArticleId><ArticleId IdType="pubmed">24955271</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsue K., Abe Y., Narita K., et al. Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years. Br. J. Haematol. 2019;187(3):328–336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900202</ArticleId><ArticleId IdType="pubmed">31267524</ArticleId></ArticleIdList></Reference><Reference><Citation>Owa M., Koyama J., Asakawa K., Hikita H., Kubo K., Ikeda S.I. Intravascular lymphomatosis presenting as reversible severe pulmonary hypertension. Int. J. Cardiol. 2000;75(2–3):283–284.</Citation><ArticleIdList><ArticleId IdType="pubmed">11186959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus M.D., Jones D., Bartlett N.L. ☆Intravascular lymphoma associated with endocrine dysfunction: a report of four cases and a review of the literature. Am. J. Med. 1999;107(2):169–176.</Citation><ArticleIdList><ArticleId IdType="pubmed">10460050</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGillivary M.L., Purdy K.S. Recommendations for an approach to random skin biopsy in the diagnosis of intravascular B-cell lymphoma. J. Cutan. Med. Surg. 2023;27(1):44–50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9902969</ArticleId><ArticleId IdType="pubmed">36205174</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsue K., Abe Y., Kitadate A., et al. Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Blood. 2019;133(11):1257–1259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450056</ArticleId><ArticleId IdType="pubmed">30647028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>